Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 6, 2007, Pages 2895-2902

  Chang, Benjamin C M ^a,b   Mirabella, Giuseppe ^a   Yagev, Ronit ^a,c   Banh, Michael ^a   Mezer, Eedy ^a   Parkin, Patricia C ^a   Westall, Carol A ^a   Buncic, J Raymond ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ALEXANDRA HOSPITAL   (Singapore)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST SENSITIVITY; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VISUAL ACUITY; ADULT; METHODOLOGY; OPTIC NERVE TUMOR; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; VISION TEST; VISUAL SYSTEM; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONTRAST SENSITIVITY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA; OPTIC NERVE NEOPLASMS; VISION SCREENING; VISUAL ACUITY; VISUAL PATHWAYS;

EID: 34347205264     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0429     Document Type: Article

References (41)

1. Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000;151:33-40.
2. Lewis RA, Riccardi VM. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology. 1984;91:929-935.
3. Stern J, Jakobiec FA, Housepian EM. The architecture of optic nerve gliomas with and without neurofibromatosis. Arch Ophthalmol. 1980;98:505-511.
4. Listernick R, Charrow J, Greenwald MJ, Esterly NB. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. 1989;114:788-792.
5. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125:63-66.
6. North K, Cochineas C, Tang E, Fagan E. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol. 1994;10:117-123.
7. Norcia AM, Tyler CW. Spatial frequency sweep VEP: visual acuity during the first year of life. Vision Res. 1985;25:1399-1408.
8. Norcia AM, Tyler CW, Hamer RD, Wesemann W. Measurement of spatial contrast sensitivity with the swept contrast VEP. Vision Res. 1989;29:627-37.
9. Tytla M, Buncic JR. Optic nerve compression impairs low spatial frequency vision in man. Clin Vision Sci. 1988;2:179-186.
10. Kupersmith, MJ, Siegel IM, Carr RE. Subtle disturbances of vision with compressive lesions of the anterior visual pathway measured by contrast sensitivity. Ophthalmology. 1982;89:68-72.
11. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575-578.
12. Norcia AM, Tyler CW. Infant VEP acuity measurements: analysis of individual differences and measurement error. Electroencephalogr Clin Neurophysiol. 1985;61:359-369.
13. Norcia AM, Tyler CW, Allen D. Electrophysiological assessment of contrast sensitivity in human infants. Am J Optom Physiol Opt. 1986;63:12-15.
14. Tyler CW, McBride B. The morphonome image psychophysics software and a calibrator for Macintosh systems. Spat Vis. 1997;10:479-484.
15. Norcia AM. PowerDiva Manual. San Francisco: Smith-Kettlewell Eye Research Institute; 1999.
16. Norcia AM, Tyler CW, Hamer RD. High visual contrast sensitivity in the young human infant. Invest Ophthalmol Vis Sci. 1988;29:44-49.
17. Norcia AM, Tyler CW, Hamer RD. Development of contrast sensitivity in the human infant. Vision Res. 1990;30:1475-1486.
18. Norcia AM, Tyler CW, Piecuch R, Clyman R, Grobstein J. Visual acuity development in normal and abnormal preterm human infants. J Pediatr Ophthalmol Strabismus. 1987;24:70-74.
19. Skoczenski AM, Norcia AM. Development of VEP vernier acuity and grating acuity in human infants. Invest Ophthalmol Vis Sci. 1999;40:2411-2417.
20. Jasper H. Report of the committee on methods of clinical examination in electroencephalography. Electroencephalogr Clin Neurophysiol. 1985;10:370-375.
21. Tang Y, Norcia AM. An adaptive filter for steady-state evoked responses. Electroencephalogr Clin Neurophysiol. 1995;96:268-277.
22. Tang Y, Norcia AM. Application of adaptive filtering to steady-state evoked response. Med Biol Eng Comput. 1995;33:391-395.
23. Vassilev A, Simeonova B. Temporal characteristics of the recognition of short lines orientation. Acta Physiol Pharmacol Bulg. 1980;6:13-22.
24. Parker DM, Salzen EA. The spatial selectivity of early and late waves within the human visual evoked response. Perception. 1977;6:85-95.
25. Parker DM, Salzen EA. Latency changes in the human visual evoked response to sinusoidal gratings. Vision Res. 1977;17:1201-1204.
26. Victor JD, Mast J. A new statistic for steady-state evoked potentials. Electroencephalogr Clin Neurophysiol. 1991;78:378-388.
27. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997;53:983-997.
28. Lauritzen L, Jorgensen MH, Michaelsen KF. Test-retest reliability of swept visual evoked potential measurements of infant visual acuity and contrast sensitivity. Pediatr Res. 2004;55:701-708.
29. Dutton JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol. 1994;38:427-452.
30. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol. 1997;41:143-149.
31. Dilts CV Carey JC, Kircher JC, et al. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J Dev Behav Pediatr. 1996;17:229-239.
32. Rossi LN, Pastorino G, Scotti G, et al. Early diagnosis of optic glioma in children with neurofibromatosis type 1. Childs Nerv Syst. 1994;10:426-429.
33. Iannaccone A, McCluney RA, Brewer VR, et al. Visual evoked potentials in children with neurofibromatosis type 1. Doc Ophthalmol. 2002;105:63-81.
34. DiMario FJ Jr, Ramsby G, Greenstein R, Langshur S, Dunham B. Neurofibromatosis type 1: magnetic resonance imaging findings. J Child Neurol. 1993;8:32-39.
35. Boycott BB, Wassle H. The morphological types of ganglion cells of the domestic cat's retina. J Physiol. 1974;240:397-419.
36. Gutowski NJ, Heron JR, Scase MO. Early impairment of foveal magno- and parvocellular pathways in juxta chiasmal tumours. Vision Res. 1997;37:1401-1408.
37. Liu GT, Lessell S. Spontaneous visual improvement in chiasmal gliomas. Am J Ophthalmol. 1992;114:193-201.
38. Packer RJ, Ater J, Allen, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg. 1997;86:747-754.
39. Gururangan S, Cavazos CM, Ashley D, et al. Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol. 2002;20:2951-2958.
40. Lacaze E, Kieffer V, Streri A, et al. Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. Br J Cancer. 2003;89:2038-2044.
41. Liu GT, Malloy P, Needle M, Phillips P. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. Pediatr Neurol. 1995;12:89-90.